Bibliography
- BAGGIOLINI M, CLARK-LEWIS I: Interleukin-8, a chemo-tactic and inflammatory cytokine. FEBS Lett. (1992) 307:97–101.
- SCHALL T: The chemokines. In: The Cytokine Handbook. A Thompson (Ed.), Academic Press, San Diego, USA (1994).
- ••A good comprehensive review of chemokines and che-mokine receptors.
- HORUK R: Chemoattractant ligands and their recep- tors. In: Pharmacology, and Toxicology: Basic and Clinical Aspects. MA Hollinger (Ed.), CRC Press, Boca Raton, USA (1996).
- ••A good comprehensive review of chemokines and che-mokine receptors.
- NAGASAWA T, HIROTA S, TACHIBANA K et al: Defects ofB-cell lymphopoiesis and bone marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Na-ture (1996) 382:635–638.
- D'SOUZA MP, HARDEN VA: Chemokines and HIV-1 sec-ond receptors - confluence of two fields generates op-timism in AIDS research. Nature Med. (1996) 2:1293–1300.
- •A good review of chemokines in the HIV-1 field.
- HORUK R: Molecular properties of the chemokine re-ceptor family. Trends Pharmacol Sci. (1994) 15:159–165.
- DOHLMAN HG, THORNER J, CARON MG, LEFKOWITZ RJ:Model systems for the study of seven transmembrane-segment receptors. Ann. Rev. Biochem,. (1991) 60:653–688.
- CHANG M, MCNINCH J, ELIAS C et al: Molecular cloning and functional characterization of a novel CC che-mokine, stimulated T cell chemotactic protein (STCP-1) that specifically acts on activated T lympho-cytes. J. Biol. Chem. (1997) 272:25229–25237.
- IMAI T, CHANTRY D, RAPORT CJ et al.: Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. (1998) 273:1764–1768.
- GODISKA R, CHANTRY D, RAPORT CJ et al.: Humanmacrophage-derived chemokine (MDC), a novel che-moattractant for monocytes, monocyte-derived den-dritic cells, and natural killer cells. J. Exp. Med. (1997) 185:1595–1604.
- ANDREW DP, CHANG MS, MCNINCH J et al.: STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by mono-cytes on stimulation with Th2 cytokines IL-4 and IL-13. Immunol. (1998) 161:5027–5038.
- PAL R, GARZINO-DEMO A, MARKHAM PD et al.: Inhibi-tion of HIV-1 infection by the beta-chemokine MDC. Science (1997) 278:695–698.
- STRUYF S, PROOST P, SOZZANI S et al.: Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived che-mokine (MDC) imply an additional MDC receptor. J. Immunol. (1998) 161:2672–2675.
- GONG J-H, CLARK-LEWIS I: Antagonists of monocytechemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J. Exp. Med. (1995) 181:631–640.
- PROUDFOOT AEI, POWER CA, HOOGEWERF AJ et al: Ex-tension of recombinant human RANTES by the reten-tion of the initiating methionine produces a potent antagonist. J. Biol. Chem. (1996) 271:2599–2603.